ActiCIDP is a monocentric academic study. Patients with Chronic inflammatory demyelinating polyradiculoneuritis may be included on a voluntary basis.
The investigators plan to include a group of approximately 40 patients with CIDP.
The investigators have planned to assess patient every three months for a year. After each visit, participants will wear Actimyo for one month daily.
Diagnosed with CIDP or possible CIDP based on 2021 EAN/PNS criteria2.
Treated with IVIg (≤1g/kg/3-8week)
Clinically Stable disease for 3 months (according to treating physician opinion).
No treatment withdrawal failure within 1 year
Significant cognitive or communication disorders
Surgery or serious traumatic injury ≤ 6 months
Non ambulant patient
Current participation to a therapeutic trial
Adults patients with Chronic inflammatory demyelinating polyradiculoneuritis
Case-only
Prospective
Actimyo
DeviceParticipants will wear 2 Actimyos in everyday life. Actimyo is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle.
95th centile of stride velocity
95th centile of stride velocity obtained with a magneto-inertial sensor (Actimyo) in real-life (meter per second).
50th centile of stride velocity
50th centile of stride velocity obtained with a magneto-inertial sensor (Actimyo) in real-life (meter per second).
95th centile of stride length
95th centile of stride length obtained with a magneto-inertial sensor (Actimyo) in real-life (meter).
50th centile of stride length
50th centile of stride length obtained with a magneto-inertial sensor (Actimyo) in real-life (meter).
Click on the lead sponsor to view all of their trials.
Centre Hospitalier Universitaire de Liege
Lead sponsor
SYSNAV
Collaborator
Centre Hospitalier Régional de la Citadelle
Collaborator
